FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Crayons Advertising IPO and Remus Pharmaceuticals IPO.
Crayons Advertising IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Remus Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.
Crayons Advertising IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Corporate Capitalventures Pvt Ltd | Beeline Capital Advisors Pvt Ltd |
Registrar | Skyline Financial Services Private Ltd | Link Intime India Private Ltd |
Market Maker | Ss Corporate Securities Limited | Sunflower Broking Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Crayons Advertising IPO is up to ₹41.80 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹47.69 Cr. The final issue price of Crayons Advertising IPO is ₹65.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.
Crayons Advertising IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹62.00 per share | ₹1,150.00 per share |
Issue Price (Upper) | ₹65.00 per share | ₹1,229.00 per share |
Issue Price (Final) | ₹65.00 per share | ₹1,229.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 2000 shares | 100 shares |
Fresh Issue Size | 64,30,000 shares | 3,88,000 shares |
Fresh Issue Size (Amount) | up to ₹41.80 Cr | up to ₹47.69 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 64,30,000 shares | 3,88,000 shares |
Issue Size Total (Amount) | up to ₹41.80 Cr | up to ₹47.69 Cr |
Crayons Advertising IPO opens on May 22, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Crayons Advertising IPO and Remus Pharmaceuticals IPO is May 25, 2023, and May 19, 2023, respectively.
Crayons Advertising IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Anchor Bid Date | May 19, 2023 | May 16, 2023 |
Issue Open | May 22, 2023 | May 17, 2023 |
Issue Close | May 25, 2023 | May 19, 2023 |
Basis Of Allotment (Tentative) | May 30, 2023 | May 24, 2023 |
Initiation of Refunds (Tentative) | May 31, 2023 | May 25, 2023 |
Credit of Share (Tentative) | Jun 01, 2023 | May 26, 2023 |
Listing date (Tentative) | Jun 02, 2023 | May 29, 2023 |
Anchor Lockin End date 1 | Jun 29, 2023 | Jun 23, 2023 |
Anchor Lockin End date 2 | Aug 28, 2023 | Aug 22, 2023 |
Crayons Advertising IPO P/E ratio is 9.39, as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.
Crayons Advertising IPO | Remus Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.75% | 92.82% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.50% | 68.37% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 9.39 | 21.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹158.80 Cr. | ₹181.03 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 0.29%% | 71.44%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 0.32%% | 69.99%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.16 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹7.04 | ₹33.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 25.39%% | 52.64%% |
In the Crayons Advertising IPO retail investors (RII) are offered 21,38,000 shares while in Remus Pharmaceuticals IPO retail investors are offered 21,38,000 shares. Qualified institutional buyers (QIB) are offered 12,22,000 shares in Crayons Advertising IPO and 1,38,750 shares in Remus Pharmaceuticals IPO.
Crayons Advertising IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Anchor Investor Reserveration | 18,30,000 shares | 1,10,500 shares |
Market Maker Reserveration | 3,22,000 shares | 19,500 shares |
QIB | 12,22,000 shares | 1,38,750 shares |
NII | 9,18,000 shares | 41,625 shares |
RII | 21,38,000 shares | 97,125 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 42,78,000 shares | 2,77,500 shares |
Crayons Advertising IPO subscribed 147.54x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.
Crayons Advertising IPO | Remus Pharmaceuticals IPO | |
---|---|---|
QIB (times) | 45.20x | 10.75x |
NII (times) | 231.59x | 229.31x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 169.94x | 49.81x |
Employee (times) | ||
Other (times) | ||
Total (times) | 147.54x | 57.21x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|